vs

Side-by-side financial comparison of LiveWire Group, Inc. (LVWR) and Verastem, Inc. (VSTM). Click either name above to swap in a different company.

LiveWire Group, Inc. is the larger business by last-quarter revenue ($11.4M vs $11.2M, roughly 1.0× Verastem, Inc.). LiveWire Group, Inc. runs the higher net margin — -155.2% vs -876.3%, a 721.1% gap on every dollar of revenue.

LiveWire is an American electric motorcycle manufacturer. It was initially launched as a dedicated electric vehicle (EV) division for Harley Davidson in July 2021. The company was spun-off from its parent and went public on September 27, 2022, via merger with a special-purpose acquisition company (SPAC). It was the first publicly traded electric motorcycle company in the United States.

Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index.

LVWR vs VSTM — Head-to-Head

Bigger by revenue
LVWR
LVWR
1.0× larger
LVWR
$11.4M
$11.2M
VSTM
Higher net margin
LVWR
LVWR
721.1% more per $
LVWR
-155.2%
-876.3%
VSTM

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
LVWR
LVWR
VSTM
VSTM
Revenue
$11.4M
$11.2M
Net Profit
$-17.6M
$-98.5M
Gross Margin
0.8%
Operating Margin
-156.2%
-362.2%
Net Margin
-155.2%
-876.3%
Revenue YoY
5.5%
Net Profit YoY
22.6%
-311.1%
EPS (diluted)
$-0.09
$-1.35

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LVWR
LVWR
VSTM
VSTM
Q4 25
$11.4M
Q3 25
$5.7M
$11.2M
Q2 25
$5.9M
$2.1M
Q1 25
$2.7M
Q4 24
$10.8M
Q3 24
$4.4M
$0
Q2 24
$6.4M
$10.0M
Q1 24
$5.0M
Net Profit
LVWR
LVWR
VSTM
VSTM
Q4 25
$-17.6M
Q3 25
$-19.4M
$-98.5M
Q2 25
$-18.8M
$-25.9M
Q1 25
$-19.3M
Q4 24
$-22.8M
Q3 24
$-22.7M
$-24.0M
Q2 24
$-24.8M
$-8.3M
Q1 24
$-23.6M
Gross Margin
LVWR
LVWR
VSTM
VSTM
Q4 25
0.8%
Q3 25
-50.9%
Q2 25
9.3%
Q1 25
-79.0%
Q4 24
-49.8%
Q3 24
-34.2%
Q2 24
-27.6%
Q1 24
-82.9%
Operating Margin
LVWR
LVWR
VSTM
VSTM
Q4 25
-156.2%
Q3 25
-330.0%
-362.2%
Q2 25
-311.0%
-2047.9%
Q1 25
-753.4%
Q4 24
-234.6%
Q3 24
-596.7%
Q2 24
-436.7%
-182.8%
Q1 24
-611.1%
Net Margin
LVWR
LVWR
VSTM
VSTM
Q4 25
-155.2%
Q3 25
-340.2%
-876.3%
Q2 25
-320.6%
-1213.6%
Q1 25
-702.6%
Q4 24
-211.7%
Q3 24
-510.6%
Q2 24
-384.6%
-82.6%
Q1 24
-475.0%
EPS (diluted)
LVWR
LVWR
VSTM
VSTM
Q4 25
$-0.09
Q3 25
$-0.10
$-1.35
Q2 25
$-0.09
$-0.62
Q1 25
$-0.09
Q4 24
$-0.11
Q3 24
$-0.11
$-0.60
Q2 24
$-0.12
$-0.31
Q1 24
$-0.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LVWR
LVWR
VSTM
VSTM
Cash + ST InvestmentsLiquidity on hand
$82.8M
$137.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$46.0M
$-15.5M
Total Assets
$146.4M
$176.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LVWR
LVWR
VSTM
VSTM
Q4 25
$82.8M
Q3 25
$16.3M
$137.7M
Q2 25
$29.3M
$164.3M
Q1 25
$46.2M
Q4 24
$64.4M
Q3 24
$88.4M
$113.2M
Q2 24
$113.0M
$83.4M
Q1 24
$141.0M
Total Debt
LVWR
LVWR
VSTM
VSTM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$40.5M
Q2 24
$40.3M
Q1 24
Stockholders' Equity
LVWR
LVWR
VSTM
VSTM
Q4 25
$46.0M
Q3 25
$61.8M
$-15.5M
Q2 25
$79.7M
$36.1M
Q1 25
$97.2M
Q4 24
$115.1M
Q3 24
$137.7M
$11.1M
Q2 24
$159.0M
$18.9M
Q1 24
$183.8M
Total Assets
LVWR
LVWR
VSTM
VSTM
Q4 25
$146.4M
Q3 25
$89.2M
$176.9M
Q2 25
$109.8M
$196.3M
Q1 25
$128.3M
Q4 24
$148.0M
Q3 24
$178.3M
$126.4M
Q2 24
$204.9M
$105.7M
Q1 24
$237.1M
Debt / Equity
LVWR
LVWR
VSTM
VSTM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
3.66×
Q2 24
2.14×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LVWR
LVWR
VSTM
VSTM
Operating Cash FlowLast quarter
$-7.9M
$-36.2M
Free Cash FlowOCF − Capex
$-8.9M
FCF MarginFCF / Revenue
-78.7%
Capex IntensityCapex / Revenue
9.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-57.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LVWR
LVWR
VSTM
VSTM
Q4 25
$-7.9M
Q3 25
$-13.3M
$-36.2M
Q2 25
$-14.9M
$-32.7M
Q1 25
$-17.5M
Q4 24
$-21.9M
Q3 24
$-23.1M
$-23.8M
Q2 24
$-26.0M
$-27.6M
Q1 24
$-22.9M
Free Cash Flow
LVWR
LVWR
VSTM
VSTM
Q4 25
$-8.9M
Q3 25
$-14.0M
Q2 25
$-16.3M
Q1 25
$-18.1M
Q4 24
$-23.3M
Q3 24
$-24.7M
Q2 24
$-27.8M
$-27.6M
Q1 24
$-26.2M
FCF Margin
LVWR
LVWR
VSTM
VSTM
Q4 25
-78.7%
Q3 25
-245.9%
Q2 25
-277.7%
Q1 25
-660.0%
Q4 24
-216.3%
Q3 24
-555.3%
Q2 24
-431.1%
-275.8%
Q1 24
-525.6%
Capex Intensity
LVWR
LVWR
VSTM
VSTM
Q4 25
9.1%
Q3 25
12.9%
Q2 25
24.3%
Q1 25
22.3%
Q4 24
13.1%
Q3 24
35.6%
Q2 24
28.5%
0.1%
Q1 24
65.1%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LVWR
LVWR

STACYC Segment$7.5M66%
Other$3.8M34%

VSTM
VSTM

Segment breakdown not available.

Related Comparisons